|
|
||||||||
Clinical Chemistry, Vol 38, 1737-1742, Copyright © 1992 by American Association for Clinical Chemistry
HC Vaidya and BG Beatty
E. I. du Pont de Nemours and Company, Inc., Medical Products, Diagnostics Systems R&D Division, Glasgow Research Laboratory, Newark, DE 19714-6101.
Heterophilic antibodies interfere in two-site immunoassays. Our purpose was to screen for the samples containing heterophilic antibodies that react with mouse immunoglobulins and to use them to determine how to eliminate interference in various two-site immunoassays being developed in our laboratory. Of approximately 2600 samples screened, 81 had heterophilic antibodies. When creatine kinase MB (CKMB) concentration was measured with intact antibody conjugate in these 81 samples, 18 (22%) samples had apparent CKMB values significantly greater than values measured with Hybritech's "Tandem -E CKMB immunoenzymetric" assay and Corning agarose-gel electrophoresis. Adding up to 133 mg/L of polymerized IgG or up to 1666 mg/L polyclonal mouse IgG in the assay did not eliminate the interference in all the samples. However, adding F(ab')2 conjugate plus 40 mg/L of polymerized IgG or 83 mg/L of polyclonal mouse IgG eliminated the interference in all the samples. This approach was also effective in eliminating the interference in 15 samples containing 4.7-165.2 mg/L of human antimouse antibody (HAMA). Combined use of F(ab')2 conjugate and polyclonal mouse IgG is recommended to eliminate interference from heterophilic antibodies that react with murine immunoglobulins or HAMA in two-site murine-antibody- based assays.
The following articles in journals at HighWire Press have cited this article:
![]() |
D. J. Warren, J. Bjerner, E. Paus, O. P. Bormer, and K. Nustad Use of an In Vivo Biotinylated Single-Chain Antibody as Capture Reagent in an Immunometric Assay to Decrease the Incidence of Interference from Heterophilic Antibodies Clin. Chem., May 1, 2005; 51(5): 830 - 838. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Eriksson, H. Halenius, K. Pulkki, J. Hellman, and K. Pettersson Negative Interference in Cardiac Troponin I Immunoassays by Circulating Troponin Autoantibodies Clin. Chem., May 1, 2005; 51(5): 839 - 847. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bjerner, O. P. Bormer, and K. Nustad The War on Heterophilic Antibody Interference Clin. Chem., January 1, 2005; 51(1): 9 - 11. [Full Text] [PDF] |
||||
![]() |
C. Roongsritong, I. Warraich, and C. Bradley Common Causes of Troponin Elevations in the Absence of Acute Myocardial Infarction: Incidence and Clinical Significance Chest, May 1, 2004; 125(5): 1877 - 1884. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Eriksson, M. Junikka, P. Laitinen, K. Majamaa-Voltti, H. Alfthan, and K. Pettersson Negative Interference in Cardiac Troponin I Immunoassays from a Frequently Occurring Serum and Plasma Component Clin. Chem., July 1, 2003; 49(7): 1095 - 1104. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Flourie, F. Parant, M. C. Penes, and D. Alcaraz-Galvain Falsely Increased Thyroid-stimulating Hormone Concentrations attributable to Interference from Human Anti-mouse Antibodies Clin. Chem., December 1, 2002; 48(12): 2289 - 2289. [Full Text] [PDF] |
||||
![]() |
R. L. Bertholf, L. Johannsen, and G. Benrubi False Elevation of Serum CA-125 Level Caused by Human Anti-Mouse Antibodies Ann. Clin. Lab. Sci., October 1, 2002; 32(4): 414 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Kim, O. F. Laterza, K. G. Hock, J. F. Pierson-Perry, D. M. Kaminski, M. Mesguich, F. Braconnier, R. Zimmermann, M. Zaninotto, M. Plebani, et al. Performance of a Revised Cardiac Troponin Method That Minimizes Interferences from Heterophilic Antibodies Clin. Chem., July 1, 2002; 48(7): 1028 - 1034. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bjerner, K. Nustad, L. F. Norum, K. H. Olsen, and O. P. Bormer Immunometric Assay Interference: Incidence and Prevention Clin. Chem., April 1, 2002; 48(4): 613 - 621. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Covinsky, O. Laterza, J. D. Pfeifer, T. Farkas-Szallasi, and M. G. Scott An IgM {lambda} Antibody to Escherichia coli Produces False-Positive Results in Multiple Immunometric Assays Clin. Chem., August 1, 2000; 46(8): 1157 - 1161. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Eriksson, M. Vehniainen, T. Jansen, V. Meretoja, P. Saviranta, K. Pettersson, and T. Lovgren Dual-Label Time-resolved Immunofluorometric Assay of Free and Total Prostate-specific Antigen Based on Recombinant Fab Fragments Clin. Chem., May 1, 2000; 46(5): 658 - 666. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Kricka Human Anti-Animal Antibody Interferences in Immunological Assays Clin. Chem., July 1, 1999; 45(7): 942 - 956. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. V. Kaplan and S. S. Levinson When Is a Heterophile Antibody Not a Heterophile Antibody? When It Is an Antibody against a Specific Immunogen Clin. Chem., May 1, 1999; 45(5): 616 - 618. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Q. Wei, V. P. Chu, A. R. Craig, J. E. Duffy, D. M. Obzansky, D. Kilgore, I. S. Masulli, C. M. Sanders, and J. C. Thompson Automated Homogeneous Immunoassay for Gentamicin on the Dimension Clinical Chemistry System Clin. Chem., March 1, 1999; 45(3): 388 - 393. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Reinsberg Interferences with Two-site Immunoassays by Human Anti-mouse Antibodies Formed by Patients Treated with Monoclonal Antibodies: Comparison of Different Blocking Reagents Clin. Chem., August 1, 1998; 44(8): 1742 - 1744. [Full Text] [PDF] |
||||
![]() |
N. Despres and A. M. Grant Antibody interference in thyroid assays: a potential for clinical misinformation Clin. Chem., March 1, 1998; 44(3): 440 - 454. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |